2015
DOI: 10.1016/j.jvs.2014.12.060
|View full text |Cite
|
Sign up to set email alerts
|

The First-in-Man “Si Se Puede” Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients with limb-threatening ischemia during endovascular therapy

Abstract: This MOXY approach appears to be safe when implanted in patients with limb-threatening ischemia undergoing endovascular recanalization and is effective in reporting local tissue oxygen concentrations over a course of 28 days. Further testing is needed to determine its potential effect on clinical decision making, both acutely on-table and chronically as a surveillance modality, which ultimately can lead to improved healing and limb salvage.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
54
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 54 publications
(54 citation statements)
references
References 28 publications
0
54
0
Order By: Relevance
“…Specifically, we have performed studies with live subjects (animal and human models) to assess the potential for successful in vivo application of similar materials. These comparable sensing systems consist of implantable hydrogel-based bioresponsive materials with longer-wavelength benzoporphyrin phosphors (with red-light excitation, compared to the green-excited phosphors used here) along with a complementary phosphorescence detection instrument with red LED and filters that match the long wavelength emission [23,36]. These studies describe a strategy that appears effective for in vivo use and should be applicable to the AnA hydrogels described here, but they will similarly require a shift to longer-wavelength phosphors to enable deeper tissue penetration.…”
Section: Resultsmentioning
confidence: 99%
“…Specifically, we have performed studies with live subjects (animal and human models) to assess the potential for successful in vivo application of similar materials. These comparable sensing systems consist of implantable hydrogel-based bioresponsive materials with longer-wavelength benzoporphyrin phosphors (with red-light excitation, compared to the green-excited phosphors used here) along with a complementary phosphorescence detection instrument with red LED and filters that match the long wavelength emission [23,36]. These studies describe a strategy that appears effective for in vivo use and should be applicable to the AnA hydrogels described here, but they will similarly require a shift to longer-wavelength phosphors to enable deeper tissue penetration.…”
Section: Resultsmentioning
confidence: 99%
“…Several hundred sensors have been optimized in mice, rats, and pigs. Over 90 sensors have been tested in humans including 50 in healthy volunteers and 40 in critical limb ischemia patients [21]. …”
Section: Methodsmentioning
confidence: 99%
“…Wearable devices are easily ignored and are useless if not actually worn. Implantable monitors (25, 26) circumvent this problem, but even minimally invasive devices may be met with resistance. Fortunately, noninvasive high-frequency health monitoring can be achieved passively during routine daily activities, overcoming the obstacle of actively modifying human behavior (Fig.…”
Section: Passive Monitoring and The Smart Home: The Engine That Nevermentioning
confidence: 99%